Trial Profile
Efficacy of raloxifene in post-menopausal women with osteopenia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jan 2015
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary)
- Indications Metabolic bone diseases; Postmenopausal osteoporosis
- Focus Therapeutic Use
- 02 Jan 2015 New trial record